Clinical trials: Bilateral Nasal Polyposis

Bilateral Nasal Polyposis

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

• Completed
• Age: 12 to 17 years
• Phase 3

This is a 16-Week Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps followed by a…

Trial name

NCT03747458

Testing

OPN-375

Where

31 sites in United States, Argentina

Volunteers

40 people

Sponsor

Optinose US Inc.